Currently, some research on CD4+ T-cells in ND patients and mouse models has found that inhibiting or removing inflammatory CD4+ T-cells (such as Th1 and Th17) or promoting the differentiation of anti-inflammatory T-cells (such as Treg) can alleviate the symptoms of NDs [63,98,171]. The gene discussed is CD4; the disease is Norrie disease.